Automated Reasoning for Application of Clinical Guidelines BMIR Research-in-Progress Presentation May 26, 2011 Csongor Nyulas, Research Software Engineer.

Slides:



Advertisements
Similar presentations
1 Using Ontologies in Clinical Decision Support Applications Samson W. Tu Stanford Medical Informatics Stanford University.
Advertisements

© 2010, American Heart Association. All rights reserved. Hospital Performance Recognition with the Get with the Guidelines Program and Mortality for Acute.
JNC 8 Guidelines….
Disease State Management The Pharmacist’s Role
The Relationship Between CMS Quality Indicators and Long-term Outcomes Among Hospitalized Heart Failure Patients Mark Patterson, Ph.D., M.P.H. Post-doctoral.
Primary care of hypertensive patients and the risk of acute events Irina Stirbu-Wagner Markus MJ Nielen Maaike Langelaan Robert A. Verheij Joke C. Korevaar.
Health Hero Network, Inc. Making Connections for Life™ Confidential – All Materials Copyright Health Hero Network, Inc Health Buddy® and Health Hero®
GLINDA: Automated Reasoning for Application of Clinical Guidelines BMIR Research-in-Progress Presentation Csongor Nyulas Samson Tu.
BioSTORM: A Test Bed for Configuring and Evaluating Biosurveillance Methods Samson W. Tu, M.S., 1 Martin J. O’Connor, M.Sc., 1 David L. Buckeridge, M.D,
HYGIA Design and Application of new Artificial Intelligence techniques to the acquisition and use of medical knowledge represented as care pathways.
Guideline interaction scenarios  At the point of care Physicians apply marked-up guidelines, thus they Need to find an appropriate guideline in “ real.
Developing an Ontology-based Metadata Management System for Heterogeneous Clinical Databases By Quddus Chong Winter 2002.
OPTIMISING MEDICINES USE GRAHAM DAVIES Professor of Clinical Pharmacy & Therapeutics Institute of Pharmaceutical Science King’s College London.
NICE in a changing world National Leading Improvement for Health and Well-being programme 12 May 2011 Gillian Mathews Implementation consultant.
Management of Hypertension according to JNC 7 BY SANDAR KYI, MD.
“Hospital Performance Recognition with the Get with the Guidelines Program and Mortality for Acute Myocardial Infarction and Heart Failure Paul A Heidenreich,
Only You Can Prevent CVD Matthew Johnson, MD. What can we do to prevent CVD?
 Maccabi is the second largest HMO in Israel. It covers 1.85 million people (24.5% 0f the population)  It is a recognized health fund within the framework.
Decision Support for Quality Improvement
SIGN CHD In Scotland in the year ending 31 March 2006 over 10,300 patients died from CHD and 5,800 from cerebrovascular disease, with.
European guidelines on the management of stable coronary artery disease Key points & new position for Ivabradine and Trimetazidine ESC 2013 Montalescot.
AN ASSESSMENT OF THE PRIMARY PREVENTION CONTROL PROGRAM OF PHC PREVENTIVE CARDIOLOGY CLINIC AMONG PATIENTS AT RISK FOR CVD: A Retrospective Cohort Study.
Methods for Computer-Aided Design and Execution of Clinical Protocols Mark A. Musen, M.D., Ph.D. Stanford Medical Informatics Stanford University.
TRANSLATING VISITS INTO PATIENTS USING AMBULATORY VISIT DATA (Hypertensive patient case study) by Esther Hing, M.P.H. and Julia Holmes, Ph.D U.S. DEPARTMENT.
Hypertension In elderly population. JNC VII BP Classification SBP mmHgDBP mmHg Normal
Basma Y. Kentab MSc.. 1. Define ambulatory care 2. Describe the value of ambulatory care practices 3. Explore pharmacy services in some ambulatory care.
Computers in Healthcare Jinbo Bi Department of Computer Science and Engineering Connecticut Institute for Clinical and Translational Research University.
LDL Program Medical Management Philip E. Johnston, Pharm.D.
Peter Emery, MD Specialist in Clinical Hypertension InterMed Portland, ME.
Improving Hypertension Quality Measurement Using Electronic Health Records S Persell, AN Kho, JA Thompson, DW Baker Feinberg School of Medicine Northwestern.
Survey of Medical Informatics CS 493 – Fall 2004 September 27, 2004.
10 Points to Remember on An Effective Approach to High Blood Pressure ControlAn Effective Approach to High Blood Pressure Control Summary Prepared by Debabrata.
Avoiding Cardiovascular Events through COMbination Therapy in Patients LIving with Systolic Hypertension The First Outcomes Trial of Initial Therapy With.
Can pharmacists improve outcomes in hypertensive patients? Sookaneknun P (1), Richards RME (2), Sanguansermsri J(1), Teerasut C (3) : (1)Faculty of Pharmacy,
HYGIA: Design and Application of New Techniques of Artificial Intelligence for the Acquisition and Use of Represented Medical Knowledge as Care Pathways.
Automated Reasoning for Application of Clinical Guidelines BMIR Research-in-Progress Presentation May 26, 2011 Csongor Nyulas, Research Software Engineer.
SSO: THE SYNDROMIC SURVEILLANCE ONTOLOGY Okhmatovskaia A, Chapman WW, Collier N, Espino J, Conway M, Buckeridge DL Ontology Description The SSO was developed.
Temporal Mediators: Integration of Temporal Reasoning and Temporal-Data Maintenance Yuval Shahar MD, PhD Temporal Reasoning and Planning in Medicine.
HvC Comparative Effectiveness Project Groups 5 and 6
Hypertension Family Medicine Specialist CME October 15-17, 2012 Pakse.
Mary Gardner, RN, MA, CCM, CDE Program Manager, High Risk Diabetes and COPD XLHealth Member Management Using The Med-eXpert System and Med-eMonitor Patient.
Quality Education for a Healthier Scotland Pharmacy Pharmaceutical Care Planning Vocational Training Scheme: Level = Stage 2 Arlene Shaw Specialist Clinical.
SPRINT What Remains Unanswered? Where Do We Go From Here? Embargoed Until 2 p.m. ET, Monday, Nov. 9, 2015.
Introduction.
Strategies to Improve Clinical Practice Through Guidelines: Experience from Recent Studies Michael Cabana (UCSF) Rebecca Beyth (University of Florida)
A collaborative scientific program E gyptian H ypertension S ociety.
Approach to building ontologies A high-level view Chris Wroe.
 Promote health, prevent illness/injury  Broad knowledge base needed to meet patient needs in different health care settings.
Impact of Multidisciplinary Team Care on Older People with Polypharmacy Liang-Kung Chen Center for Geriatrics and Gerontology Taipei Veterans General Hospital.
SAGE Nick Beard Vice President, IDX Systems Corp..
The Role of Health Information Technology in Implementing Disease Management Programs Donald F. Wilson, MD Medical Director Quality Insights of Pennsylvania.
Treatment Guidelines and Disease State Management Presentation Developed for the Academy of Managed Care Pharmacy Updated: February 2015.
References 1.Buse JB, Ginsberg HN, Bakris GL, et al. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement.
Ten Year Outcome of Coronary Artery Bypass Graft Surgery Versus Medical Therapy in Patients with Ischemic Cardiomyopathy Results of the Surgical Treatment.
Documentation in Practice Dept. of Clinical Pharmacy.
Date of download: 6/23/2016 From: Screening for, Monitoring, and Treatment of Chronic Kidney Disease Stages 1 to 3: A Systematic Review for the U.S. Preventive.
Date of download: 9/17/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Application of the Screening for Heart Attack Prevention.
Date of download: 9/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: Presidential address: quality of cardiovascular.
How Do We Individualize Guidelines in an Era of Personalized Medicine? Douglas K. Owens, MD, MS VA Palo Alto Health Care System Stanford University, Stanford.
Management of Hypertension according to JNC 7
The SPRINT Research Group
Hypertension in the Post SPRINT era
Hypertension JNC VIII Guidelines.
How does teamwork improve value. Dr Nils E
Systolic Blood Pressure Intervention Trial (SPRINT)
RCHC’s Cardiovascular Health Initiative
Table of Contents Why Do We Treat Hypertension? Recommendation 5
Pharmaceutical care planning 2 Ola Ali Nassr
Beth Wallace, BSN, RN-BC, FNP-S Fairfield University Summer 2010
Director, Global Terminology and Data Operations
Presentation transcript:

Automated Reasoning for Application of Clinical Guidelines BMIR Research-in-Progress Presentation May 26, 2011 Csongor Nyulas, Research Software Engineer Samson Tu, Senior Research Scientist

GLINDA: Guideline Interaction Detection Architecture Funder: National Library of Medicine Project Members Mark Musen Mary Goldstein Samson Tu Susana Martins Csongor Nyulas Hyunggu Jung Pamela Kum

Agenda Background and goals Method Status and future work

Problem Statement Populations are aging worldwide Older adults tend to have multiple chronic conditions 75 million in US have 2 or more concurrent chronic conditions [1] Management of multiple comorbidities presents challenging problems Multiple competing goals Variability in priorities [2] Different risk profiles [3] [1] Anand K. Parekh, Mary B. Barton, The Challenge of Multiple Comorbidity for the US Health Care System, JAMA. 2010;303(13): [2] Tinetti ME, McAvay GJ, Fried TR, Allore HG, Salmon JC, Foody JM, et al. Health outcome priorities among competing cardiovascular, fall injury, and medication-related symptom outcomes. J Am Geriatr Soc Aug;56(8): [3] Fraenkel L, Fried TR. Individualized Medical Decision Making: Necessary, Achievable, but Not Yet Attainable. Arch Intern Med March 22, 2010;170(6):566-9.

Role of Clinical Practice Guidelines Clinical practice guidelines define standard of care Almost all clinical practice guidelines focus on the management of single diseases Simultaneous application of multiple guidelines leads to suboptimal care [1] Hypothetical 79-year-old woman with chronic obstructive pulmonary disease, type 2 diabetes, osteoporosis, hypertension, and osteoarthritis If the relevant CPGs were followed, the hypothetical patient would be prescribed 12 medications and a complicated nonpharmacological regimen [1] Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA Aug 10;294(6):716-24

Long-Term Research Goals Develop a modular and extensible platform for exploring informatics and clinical issues Integrate and reuse best-of-breed knowledge resources and applications Enumerate the ways that guideline recommendations interact and develop a theory on how to accommodate the interactions Create methods for detecting, repairing, prioritizing, and integrating treatment recommendations from multiple guidelines

Examples To manage uncontrolled blood pressure, non- dihydropyridines calcium channel blocker (NCCB) is a possible alternative if the patient had a recent myocardial infarction (MI) In the heart-failure guideline, MI is a contraindication for the use of NCCB in patient with low left ventricular ejection fraction (LVEF) A patient whose blood pressure is not controlled, who had a recent MI and who has low LVEF will have contradictory recommendations on the use of NCCB

Overview of Approach Adapt our previously developed BioSTORM agent architecture Task decomposition Problem-solving method Reuse our extensive experience with ATHENA CDS Clinical domains: Hypertension (HTN), diabetes mellitus (DM), heart failure (HF), hyperlipidemia (Lipid), chronic kidney disease (CKD) Develop ontology of guideline interactions Develop new agents for detecting, repairing, prioritizing, and integrating treatment recommendations Apply methods on anonymized patient cases from the Stanford STRIDE database

Outline of Method Section STRIDE patient selection and preparation BioSTORM agent architecture and its application to GLINDA ATHENA CDS agents Integrated view of CDS recommendations Ontology of guideline interactions New agents for detecting, repairing and integrating guideline recommendations

Outline of Method Section STRIDE patient selection and preparation BioSTORM agent architecture and its application to GLINDA ATHENA CDS agents Integrated view of CDS recommendations Ontology of guideline interactions New agents for detecting, repairing and integrating guideline recommendations

STRIDE Data Extraction Stanford Translational Research Integrated Database Environment (STRIDE) Structured clinical information on over 1.4 million pediatric and adult patients cared for at Stanford University Medical Center since 1995 Inclusion criteria Adults who have ICD 9 codes for 2 or more of HTN, HF, DM, Lipid disorder, CKD, acute Myocardial Infarction (MI) or Coronary Artery Disease (CAD) Anonymized data extraction specification Demographics, vital signs, problems, medications, adverse reactions, selected blood and urine test results All dates converted to time-since-birthday 2455 cases

Test Patients Selection

Data Preparation Map DB terms to ATHENA KB terms Process data (e.g., compute daily doses) Note: Compute “date” by assuming everyone’s birthday to be

Outline of Method Section STRIDE patient selection and preparation BioSTORM agent architecture and its application to GLINDA ATHENA CDS agents Integrated view of CDS recommendations Ontology of guideline interactions New agents for detecting, repairing and integrating guideline recommendations

BioSTORM: A Test Bed for Configuring and Evaluating Biosurveillance Methods Task-method decomposition of biosurveillance algorithms and evaluations Ontology of task and methods Instances of specific biosurveillance configuration Agent-based architecture for configuration and implementation of tasks and methods Buckeridge DL, Okhmatovskaia A, Tu S, O'Connor M, Nyulas C, Musen MA. Understanding detection performance in public health surveillance: modeling aberrancy- detection algorithms. J Am Med Inform Assoc2008 Nov-Dec;15(6):760-9

Task-Method Decomposition Tasks are defined by inputs and output. Methods are specified by semantic properties characterized as configuration parameters, input data, or computed results.

Representation of EARS C- Family Algorithms Obtain Current Observation Binary Alarm Transform Data Forecast Compute Test Value Estimate Model Parameters Obtain Baseline Data Evaluate Test Value Compute Expectation Empirical Forecasting Partial Summation Mean, StDev Database Query (7 days) Database Query (single day) Aberrancy Detection (Temporal) Obtain Current Observation-1 Compute Test Value-1 Estimate Model Parameters-1 Obtain Baseline Data-1 Evaluate Test Value-1 baseline mean, SD current observation 7 days baseline data current date partial sum alarm value a. Task structureb. Algorithmic flow

GLINDA Agents and Algorithmic Flow

Example of Agent Configuration: Get-Data Agent Task Method

Operation of Get-Data Agent Blackboard agent Controller agent Task-method ontology GLINDA agent configuration Configurator agent Monitor agent Get-data agent Data

Blackboard agent Controller agent Task-method ontology GLINDA agent configuration Configurator agent Monitor agent Get-data agentData System Architecture ATHENA agents ATHENA KBs Select guideline agent Consolidator agent Prioritized Integrated Recommendations Interaction agents Repair & prioritize agents

Outline of Method Section STRIDE patient selection and preparation BioSTORM agent architecture and its application to GLINDA ATHENA CDS agents Integrated view of CDS recommendations Ontology of guideline interactions New agents for detecting, repairing and integrating guideline recommendations

What is ATHENA CDS? Automated clinical decision support system (CDSS) Knowledge-based system automating guidelines Built with EON technology for guideline-based decision support, developed at Stanford Medical Informatics Initially for patients with primary hypertension who meet eligibility criteria Extended to patients with chronic pain, heart failure, diabetes mellitus, chronic kidney disease and hyperlipidemia Patient specific information and recommendations at the point of care Goldstein MK, et al. Translating research into practice: organizational issues in implementing automated decision support for hypertension in three medical centers. J Am Med Inform Assoc2004 Sep-Oct;11(5):

SYNTHETIC PATIENT DATA ONLY; no PHI

25 SYNTHETIC PATIENT DATA

ATHENA-HTN Implementation San Francisco VA Palo Alto VA Durham VAMC, North Carolina VISN 1 sites: Bedford, MA Boston, MA Manchester, NH Providence, RI West Haven, CT Three-Site Study: 50+ Providers 5,000+ Patients Almost 10,000 clinic visits VISN 1 Study: 50+ Providers 7,000+ Patients 11,000+ clinic visits Information displayed to providers for….

Electronic Medical Record System Patient Data Simplified ATHENA Architecture ATHENA Guideline Knowledge Bases Guideline Interpreter Treatment Recommendation SQL Server: Relational database Data Mediator Method input output

Configuration of ATHENA CDS Agent: Class Definitions ATHENA Method Apply Guideline Task Annotations on property types Properties of method

Configuration of ATHENA CDS Agent: Instances ATHENA CDS Method Configuration Apply HTN Guideline Task

Outline of Method Section STRIDE patient selection and preparation BioSTORM agent architecture and its application to GLINDA ATHENA CDS agents Integrated view of CDS recommendations Ontology of guideline interactions New agents for detecting, repairing and integrating guideline recommendations Presentation for review

Single Guideline CDS Recommendation

Consolidating Recommendations from Multiple Guidelines

Outline of Method Section STRIDE patient selection and preparation BioSTORM agent architecture and its application to GLINDA ATHENA CDS agents Integrated view of CDS recommendations Ontology of guideline interactions New agents for interaction detection, repair and for integrating guideline recommendations

Ontology of Guideline Interactions: Approaches Types of interactions Goals Recommended interventions Guideline abstractions Cumulative effects Quantitative Approach Decision analysis Quality-Adjusted Life Years (QALY) Qualitative Approach Leverage existing guidelines Focus on integration and prioritization of guideline recommendations

Structure of Recommendations

Taxonomy of Cross-Guideline Relationships Among Recommendations For each intervention, given a patient’s condition Consistently positive Consistently negative Collateral effect Indicated in one guideline, no specific indication in second Contradictory Indicated in one guideline, relative contraindications in another Contraindicated Strong contraindication in one guideline Mixed Indications and relative contraindications in both guidelines Cumulative number of recommendations

Detecting Interactions (defrule Contradictory-benefit-risk-detection-1 (object (is-a Advisory) (evaluated_interventions $? ?ev $?)) (object (is-a Evaluated_Intervention) (activity ?intervention) (evaluations $? ?g1-evaluation $? ?g2-evaluation $?)(OBJECT ?ev)) (object (is-a Intervention_Evaluation)(add ?g1-addEval)(OBJECT ?g1-evaluation)) (object (is-a Intervention_Evaluation)(add ?g2-addEval)(OBJECT ?g2-evaluation)) (object (is-a Add_Evaluation)(OBJECT ?g1-addEval) (compelling_indication $?ci)(relative_indication $?ri) (contraindication nil)(relative_contraindication nil)) (object (is-a Add_Evaluation)(OBJECT ?g2-addEval) (compelling_indication nil)(relative_indication nil) (contraindication nil)(relative_contraindication $?rc)) => (make-instance Contradiction-Interaction (indication-evaluations ?g1-addEval) (contraindication-evaluation ?g2-addEval)) )

Prioritizing Guidelines and Recommendations Prioritizing guidelines Manual selection Silence guideline if guideline targets (e.g., BP) satisfied Prioritizing recommendations Ranking based on importance of goals? Ranking based on weighted average of indications/contraindications?? Constrain the total number of recommended interventions?? ???

Current Status

Future Work Extend the ontology of guideline interactions e.g., Timing of interventions Dosing differences Reasoning based on drug properties Develop quantitative methods?? Grant proposal?

Funding Support Protégé : National Institutes of Health (NLM LM007885) BioSTORM: Centers for Disease Control and Prevention (RFA-PH ) EON: National Institutes of Health (NLM LM05708) GLINDA: National Institutes of Health (NLM HHSN C)

Funding Support ATHENA-CDS ATHENA-CDS supported in part by: VA HSR&D IMV : VISN Collaborative for Improving Hypertension Management with ATHENA-HTN VA HSR&D CPI : Guidelines for Drug Therapy of Hypertension: Multi-site Implementation Project VA HSR&D CPG : Guidelines for Drug Therapy of Hypertension: Closing the Loop VA HSR&D RRP : ATHENA-HF: Integrating Computable Guidelines for Complex Co-Morbidities PAIRE at VA Palo Alto, Pilot Project for ATHENA-DM VA HSR&D SDR and VA HSR&D IMA ; PI: Denise Hynes. ATHENA-CKD knowledge base.